(E)-4-(2-((4-Chlorobenzyl)sulfonyl)vinyl)benzoic acid
Title | Journal |
---|---|
Effects of formulation and route of administration on the systemic availability of Ex-RAD®, a new radioprotectant, in preclinical species. | Biopharmaceutics & drug disposition 20110301 |